SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1i9r'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HUO_A_PNNA302_0
(CTX-M-9
EXTENDED-SPECTRUM
BETA-LACTAMASE)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
4 / 6 LEU H 194
GLY H 195
ALA H 130
PRO H 131
None
0.31A 3huoA-1i9rH:
undetectable
3huoA-1i9rH:
23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JX1_B_CAMB502_0
(CAMPHOR
5-MONOOXYGENASE)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 10 PHE H 127
GLY H 123
THR H 210
VAL H 203
VAL H 212
None
1.19A 4jx1B-1i9rH:
undetectable
4jx1B-1i9rH:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qvnH-1i9rH:
undetectable
4qvnI-1i9rH:
undetectable
4qvnH-1i9rH:
21.32
4qvnI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVN_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 10 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qvnV-1i9rH:
0.0
4qvnW-1i9rH:
0.2
4qvnV-1i9rH:
21.32
4qvnW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.83A 4qvpH-1i9rH:
undetectable
4qvpI-1i9rH:
undetectable
4qvpH-1i9rH:
21.32
4qvpI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVP_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.83A 4qvpV-1i9rH:
undetectable
4qvpW-1i9rH:
undetectable
4qvpV-1i9rH:
21.32
4qvpW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qvqH-1i9rH:
undetectable
4qvqI-1i9rH:
undetectable
4qvqH-1i9rH:
21.32
4qvqI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVQ_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qvqV-1i9rH:
0.0
4qvqW-1i9rH:
0.1
4qvqV-1i9rH:
21.32
4qvqW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.87A 4qvvH-1i9rH:
undetectable
4qvvH-1i9rH:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVV_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qvvV-1i9rH:
undetectable
4qvvV-1i9rH:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qvyH-1i9rH:
undetectable
4qvyH-1i9rH:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QVY_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qvyV-1i9rH:
undetectable
4qvyW-1i9rH:
undetectable
4qvyV-1i9rH:
21.32
4qvyW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qw0H-1i9rH:
undetectable
4qw0I-1i9rH:
undetectable
4qw0H-1i9rH:
21.32
4qw0I-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW0_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qw0V-1i9rH:
undetectable
4qw0W-1i9rH:
undetectable
4qw0V-1i9rH:
21.32
4qw0W-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qw1H-1i9rH:
undetectable
4qw1I-1i9rH:
undetectable
4qw1H-1i9rH:
21.32
4qw1I-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QW1_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.86A 4qw1V-1i9rH:
undetectable
4qw1W-1i9rH:
undetectable
4qw1V-1i9rH:
21.32
4qw1W-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qwuH-1i9rH:
0.0
4qwuI-1i9rH:
undetectable
4qwuH-1i9rH:
21.32
4qwuI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QWU_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qwuV-1i9rH:
0.0
4qwuW-1i9rH:
0.2
4qwuV-1i9rH:
21.32
4qwuW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5BXN_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 5bxnH-1i9rH:
undetectable
5bxnI-1i9rH:
undetectable
5bxnH-1i9rH:
21.32
5bxnI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CZ7_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 5cz7V-1i9rH:
undetectable
5cz7W-1i9rH:
undetectable
5cz7V-1i9rH:
21.32
5cz7W-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5D0X_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 5d0xV-1i9rH:
undetectable
5d0xV-1i9rH:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IK1_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 7 PHE H 127
GLY H 123
THR H 210
VAL H 203
VAL H 212
None
1.34A 5ik1A-1i9rH:
undetectable
5ik1A-1i9rH:
18.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.82A 5l5fH-1i9rH:
undetectable
5l5fI-1i9rH:
undetectable
5l5fH-1i9rH:
21.32
5l5fI-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L5F_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.82A 5l5fV-1i9rH:
undetectable
5l5fW-1i9rH:
undetectable
5l5fV-1i9rH:
21.32
5l5fW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_H_BO2H301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.84A 5l66H-1i9rH:
undetectable
5l66I-1i9rH:
undetectable
5l66H-1i9rH:
21.32
5l66I-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L66_V_BO2V301_1
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.84A 5l66V-1i9rH:
undetectable
5l66W-1i9rH:
undetectable
5l66V-1i9rH:
21.32
5l66W-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_H_BO2H301_0
(PROTEASOME SUBUNIT
BETA TYPE-2
PROTEASOME SUBUNIT
BETA TYPE-3)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 12 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.90A 6hwdH-1i9rH:
undetectable
6hwdI-1i9rH:
undetectable
6hwdH-1i9rH:
18.56
6hwdI-1i9rH:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HWD_V_BO2V301_0
(PROTEASOME SUBUNIT
BETA TYPE-2)
1i9r IMMUNOGLOBULIN H
(Homo
sapiens)
5 / 11 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.90A 6hwdV-1i9rH:
undetectable
6hwdV-1i9rH:
18.56